Study reveals best ways to adjust ulcerative colitis treatment for better living
NCT ID NCT05271773
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 234 adults with ulcerative colitis whose gut lining had healed (Mayo 0 or 1). Researchers tracked how increasing, decreasing, or switching treatments affected patients' quality of life over 6 and 12 months. They also measured inflammation markers like fecal calprotectin. The goal was to find the best treatment approach for maintaining well-being.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBD (INFLAMMATORY BOWEL DISEASE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Marqués de Valdecilla
Santander, Cantabria, 39008, Spain
-
Hospital Universitari Parc Taulí
Sabadell, Catalonia, 08208, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario La Princesa
Madrid, 28006, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, 28034, Spain
-
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz De Tenerife, 38018, Spain
-
Hospital Universitario de Cáceres
Cáceres, Extremadura, 10004, Spain
-
Hospital Universitario de Santiago de Compostela
Santiago de Compostela, Galicia, 15706, Spain
-
Hospital Universitario. Miguel Servet
Zaragoza, 50009, Spain
-
Hospital de Santa Bárbara de Puertollano
Puertollano, Ciudad Real, 13500, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sleep hormone melatonin put to the test for IBD patients with poor sleep
- Which diet do IBD patients prefer? intermittent fasting, mediterranean, or low FODMAP?
- New drug D-2570 aims to quiet Flare-Ups in ulcerative colitis
- Could a postbiotic soothe irritable bowel syndrome?
- Podcast vs. pamphlet: which boosts IBD knowledge best?
- New oral drug for inflammatory bowel disease enters first human tests